DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Inagaki N, Kondo K, Yoshinari T. et al.
Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, 12-week study.
Diabetes Obes Metab 2013;
15: 1136-1145
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.